Nanotechnology Identifies Peptide "Fingerprint" in Both Forms of ALS

A nanotechnology developed by a University at Buffalo professor has enabled researchers to identify a molecular signature common to both familial and sporadic cases of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news108142317.html">Nanotechnology Identifies Peptide "Fingerprint" in Both Forms of ALS</a></p> <p>A nanotechnology developed by a University at Buffalo professor has enabled researchers to identify a molecular signature common to both familial and sporadic cases of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease.</p>